Mankind Pharma is exploring investment projects in Uzbekistan
As part of his business trip to the Republic of India, Abdulla Azizov, Director of the Agency for the Development of the Medical and Pharmaceutical Sector, met with Ramesh Juneja, Chairman of one of the country's leading pharmaceutical companies, Mankind Pharma.
Mankind Pharma is considering investment projects in Uzbekistan
Tashkent, Uzbekistan (UzDaily.uz) — During a business trip to the Republic of India, Abdulla Azizov, Director of the Agency for the Development of Medicine and Pharmaceutical Industries, met with Ramesh Juneja, Chairman of one of the country's leading pharmaceutical companies - Mankind Pharma.
During the negotiations, the parties discussed the prospects for implementing investment projects in Uzbekistan, expanding the production of modern medicines, establishing cooperation in the field of research and innovative development (R&D), as well as technology transfer and the organization of high-value-added production in the pharmaceutical industry.
The meeting included a presentation of the pharmaceutical cluster "BioPharma City", detailed information about its capabilities, favorable conditions created for foreign investors, as well as tax and customs privileges provided for the implementation of investment projects.
The management of Mankind Pharma highly appreciated the opportunities created for the development of the pharmaceutical industry in Uzbekistan and expressed interest in jointly developing specific areas of investment cooperation and implementing promising projects.
Founded in 1995, Mankind Pharma is one of the largest pharmaceutical companies in India, producing prescription and non-prescription medicines, as well as consumer health products. The company's products are exported to more than 70 countries and successfully operate in international markets.